The Evolving Therapeutic Landscape for Becker Muscular Dystrophy: An Update Part 1

The Evolving Therapeutic Landscape for Becker Muscular Dystrophy_An Update - Part 2Подробнее

Protecting Muscle in DMD and BMD: Results from Edgewise’s Phase 1 Trial in Adults with BMDПодробнее

The Evolving Therapeutic Landscape for BMD: An Update - Part 3 presented by Edgewise TherapeuticsПодробнее

Duchenne & Becker muscular dystrophy - causes, symptoms, treatment & pathologyПодробнее

Breakout Session: Emerging Therapies for Becker Muscular Dystrophy - PPMD 2022 Annual ConferenceПодробнее

Management of Duchenne Muscular Dystrophy - An UpdateПодробнее

EDG-5506 Dose 1 For Becker Muscular Dystrophy (NCT05291091)Подробнее

A Novel Approach to Protect Muscle in DMD and BMD - presented by Edgewise TherapeuticsПодробнее

Webinar: INSPIRE DUCHENNE Clinical Trial Update and Study ExpansionПодробнее

Becker Muscular DystrophyПодробнее

New Developments and Treatment in Neuromuscular Diseases | UPMC Children'sПодробнее

MDA Engage Webinar: Updates in BMD: Genetic TestingПодробнее

My future with Limb Girdle Muscular DystrophyПодробнее

The Evolving Landscape of Gene Therapy for Neuromuscular Disorders by Dr. Tom FlaniganПодробнее

Biglyca: An Emerging Therapy for Duchenne Muscular DystrophyПодробнее

gower's sign | muscle disease | duchenne muscular dystrophy | myopathy #shortsПодробнее

Innovative Therapies: Session 1Подробнее

PS121 Week 4 - Chamberlain Gene Therapy for Muscular Dystrophies 1 1080PПодробнее

BECKER MUSCULAR DYSTROPHYПодробнее